ArticleJournal of translational medicine2026

The Beclin1‑Targeting stapled peptide suppresses colorectal cancer progression by disrupting EGFR/β-catenin axis.

Mingyuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.